These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2245970)

  • 1. Effects of growth hormone on body composition in adults.
    Christiansen JS; Jørgensen JO; Pedersen SA; Møller J; Jørgensen J; Skakkeboek NE
    Horm Res; 1990; 33 Suppl 4():61-4. PubMed ID: 2245970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.
    Jørgensen JO; Vahl N; Hansen TB; Thuesen L; Hagen C; Christiansen JS
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):681-8. PubMed ID: 9039333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supraphysiological growth hormone: less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults.
    Ehrnborg C; Ellegård L; Bosaeus I; Bengtsson BA; Rosén T
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):449-57. PubMed ID: 15807876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double-blind, randomized, placebo-controlled study.
    Hansen TB; Vahl N; Jørgensen JO; Christiansen JS; Hagen C
    Clin Endocrinol (Oxf); 1995 Dec; 43(6):689-96. PubMed ID: 8736270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men.
    de Boer H; Blok GJ; Voerman B; Derriks P; van der Veen E
    Int J Obes Relat Metab Disord; 1996 Jun; 20(6):580-7. PubMed ID: 8782736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis.
    de Boer H; Blok GJ; Voerman B; de Vries P; Popp-Snijders C; van der Veen E
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2069-76. PubMed ID: 7608257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in body composition during 12 months after discontinuation of growth hormone therapy in young adults with growth hormone deficiency from childhood.
    Stouthart PJ; de Ridder CM; Rekers-Mombarg LT; van der Waal HA
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():335-8. PubMed ID: 10698598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.
    Bengtsson BA; Edén S; Lönn L; Kvist H; Stokland A; Lindstedt G; Bosaeus I; Tölli J; Sjöström L; Isaksson OG
    J Clin Endocrinol Metab; 1993 Feb; 76(2):309-17. PubMed ID: 8432773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience.
    Hwu CM; Kwok CF; Lai TY; Shih KC; Lee TS; Hsiao LC; Lee SH; Fang VS; Ho LT
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3285-92. PubMed ID: 9329355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity.
    Richelsen B; Pedersen SB; Børglum JD; Møller-Pedersen T; Jørgensen J; Jørgensen JO
    Am J Physiol; 1994 Feb; 266(2 Pt 1):E211-6. PubMed ID: 8141279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T; Mulder P; Hokken-Koelega A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Soft tissue changes in adults with acquired growth hormone deficiency during substitution treatment. A double-blind, randomized, placebo-controlled study after a year of treatment].
    Hansen TB; Vahl N; Jørgensen JO; Christiansen JS; Hagen C
    Ugeskr Laeger; 1997 Jul; 159(28):4394-9. PubMed ID: 9235736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.
    Weaver JU; Monson JP; Noonan K; John WG; Edwards A; Evans KA; Cunningham J
    J Clin Endocrinol Metab; 1995 Jan; 80(1):153-9. PubMed ID: 7829604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
    Biller BM; Sesmilo G; Baum HB; Hayden D; Schoenfeld D; Klibanski A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):970-6. PubMed ID: 10720025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term growth hormone treatment in growth hormone deficient adults.
    Jørgensen JO; Pedersen SA; Thuesen L; Jørgensen J; Møller J; Müller J; Skakkebaek NE; Christiansen JS
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):449-53. PubMed ID: 1759534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.
    Cuneo RC; Judd S; Wallace JD; Perry-Keene D; Burger H; Lim-Tio S; Strauss B; Stockigt J; Topliss D; Alford F; Hew L; Bode H; Conway A; Handelsman D; Dunn S; Boyages S; Cheung NW; Hurley D
    J Clin Endocrinol Metab; 1998 Jan; 83(1):107-16. PubMed ID: 9435425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.
    Mogul HR; Lee PD; Whitman BY; Zipf WB; Frey M; Myers S; Cahan M; Pinyerd B; Southren AL
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1238-45. PubMed ID: 18211968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
    Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
    Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.